These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24062151)

  • 1. [Tear in the retinal pigment epithelium by intravitreal injection of aflibercept].
    Bertelmann T; Sekundo W; Wenner Y
    Ophthalmologe; 2014 Aug; 111(8):775-7. PubMed ID: 24062151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full thickness macular hole case after intravitreal aflibercept treatment.
    Oshima Y; Apte RS; Nakao S; Yoshida S; Ishibashi T
    BMC Ophthalmol; 2015 Mar; 15():30. PubMed ID: 25881212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective PED-study of intravitreal aflibercept for refractory vascularized pigment epithelium detachment due to age-related macular degeneration: morphologic characteristics of non-responders in optical coherence tomography.
    Clemens CR; Alten F; Termühlen J; Mihailovic N; Rosenberger F; Heiduschka P; Eter N
    Graefes Arch Clin Exp Ophthalmol; 2020 Jul; 258(7):1411-1417. PubMed ID: 32306096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD. Frequency and progress].
    Kook D; Wolf A; Neubauer AS; Haritoglou C; Priglinger SG; Kampik A; Ulbig MW
    Ophthalmologe; 2008 Feb; 105(2):158-64. PubMed ID: 17653552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OUTCOME OF INTRAVITREAL AFLIBERCEPT FOR REFRACTORY PIGMENT EPITHELIAL DETACHMENT WITH OR WITHOUT SUBRETINAL FLUID AND SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
    Kim K; Kim ES; Kim Y; Yang JH; Yu SY; Kwak HW
    Retina; 2019 Feb; 39(2):303-313. PubMed ID: 29160779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WRINKLED VASCULARIZED RETINAL PIGMENT EPITHELIUM DETACHMENT PROGNOSIS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
    Lam D; Semoun O; Blanco-Garavito R; Jung C; Nguyen DT; Souied EH; Mimoun G
    Retina; 2018 Jun; 38(6):1100-1109. PubMed ID: 28520639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.
    Chan CK; Meyer CH; Gross JG; Abraham P; Nuthi AS; Kokame GT; Lin SG; Rauser ME; Kaiser PK
    Retina; 2007 Jun; 27(5):541-51. PubMed ID: 17558314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab.
    Patel KH; Chow CC; Rathod R; Mieler WF; Lim JI; Ulanski LJ; Leiderman YI; Arun V; Chau FY
    Eye (Lond); 2013 May; 27(5):663-7; quiz 668. PubMed ID: 23558214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term visual outcome of pigment epithelial tears in association with anti-VEGF therapy of pigment epithelial detachment in AMD.
    Gutfleisch M; Heimes B; Schumacher M; Dietzel M; Lommatzsch A; Bird A; Pauleikhoff D
    Eye (Lond); 2011 Sep; 25(9):1181-6. PubMed ID: 21701525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal pigment epithelial tear after intravitreal aflibercept for neovascular age-related macular degeneration.
    Sato T; Ooto S; Suzuki M; Spaide RF
    Ophthalmic Surg Lasers Imaging Retina; 2015 Jan; 46(1):87-90. PubMed ID: 25559517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.
    Ronan SM; Yoganathan P; Chien FY; Corcóstegui IA; Blumenkranz MS; Deramo VA; Elner SG; Fastenberg DA; Johnson MW; López M; Mateo C; Moshfeghi DM; Navarro R; Rosenblatt BJ; Sanislo SR; Saxe SJ; Zacks DN
    Retina; 2007 Jun; 27(5):535-40. PubMed ID: 17558313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. INCIDENCE AND LONG-TERM VISUAL ACUITY OUTCOMES OF RETINAL PIGMENT EPITHELIUM TEARS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Vazquez-Alfageme C; Nicholson L; Hamilton RD; Patel PJ
    Retina; 2019 Apr; 39(4):664-669. PubMed ID: 29324593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-VEGF and its impact on the outer retina: retinal pigment epithelium tear after an injection of aflibercept in contralateral eye.
    Campos Polo R; Rubio Sánchez C
    Arch Soc Esp Oftalmol; 2016 May; 91(5):245-9. PubMed ID: 26899882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term outcomes of switching anti-VEGF agents in eyes with treatment-resistant wet AMD.
    Batioglu F; Demirel S; Özmert E; Abdullayev A; Bilici S
    BMC Ophthalmol; 2015 Apr; 15():40. PubMed ID: 25885684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FLATTENING OF A TREATMENT-RESISTANT RETINAL PIGMENT EPITHELIAL DETACHMENT AFTER A SINGLE INTRAVITREAL INJECTION OF ZIV-AFLIBERCEPT.
    Yogi R; Stewart M; Chhablani J
    Retin Cases Brief Rep; 2017 Spring; 11(2):111-113. PubMed ID: 27078613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ranibizumab versus aflibercept for the treatment of vascularized pigment epithelium detachment due to age-related macular degeneration.
    Rouvas A; Chatziralli I; Androu A; Mpougatsou P; Alonistiotis D; Douvali M; Kabanarou SA; Theodossiadis P
    Int Ophthalmol; 2019 Feb; 39(2):431-440. PubMed ID: 29404860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections.
    Chan CK; Abraham P; Meyer CH; Kokame GT; Kaiser PK; Rauser ME; Gross JG; Nuthi AS; Lin SG; Daher NS
    Retina; 2010 Feb; 30(2):203-11. PubMed ID: 19952998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of intravitreal injection of aflibercept in neovascular age-related macular degeneration with or without choroidal vascular hyperpermeability.
    Hata M; Oishi A; Tsujikawa A; Yamashiro K; Miyake M; Ooto S; Tamura H; Nakanishi H; Takahashi A; Yoshikawa M; Yoshimura N
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):7874-80. PubMed ID: 25395483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal and Choroidal Changes after Anti Vascular Endothelial Growth Factor Therapy for Neovascular Age-related Macular Degeneration.
    Kim SW; Woo JE; Yoon YS; Lee S; Woo JM; Min JK
    Curr Pharm Des; 2019; 25(2):184-189. PubMed ID: 30892159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-responsiveness to intravitreal aflibercept treatment in neovascular age-related macular degeneration: implications of serous pigment epithelial detachment.
    Nagai N; Suzuki M; Uchida A; Kurihara T; Kamoshita M; Minami S; Shinoda H; Tsubota K; Ozawa Y
    Sci Rep; 2016 Jul; 6():29619. PubMed ID: 27403807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.